Earnings Snapshot: Novavax beats Q2 top and bottom line estimates;raises FY26 adjusted rev
Earnings Snapshot: Novavax beats Q2 top and bottom line estimates; raises FY26 adjusted total revenue outlook
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Earnings Snapshot: Novavax beats Q2 top and bottom line estimates; raises FY26 adjusted total revenue outlook
Earnings Snapshot: Novavax beats Q2 top and bottom line estimates;raises FY26 adjusted rev | Seeking Alpha
More on Novavax
Novavax: The Beaten-Down COVID-19 Darling
Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold
Novavax GAAP EPS of -$0.32 beats by $0.06, revenue of $57M beats by $3.7M
U.S. advises against Congo travel after second American aid worker contracts Ebola
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Cheniere Energy Partners GAAP EPS of $2.14 beats by $1.18, revenue of $2.58B misses by $40M (CQP:NYSE)
Cheniere Energy Partners (CQP) Q2 earnings: EPS beat, revenue miss, and 2026 distribution guidance reaffirmed at $3.10â$3.40.
Zai Lab reports Q2 results (ZLAB:NASDAQ)
Zai Lab (ZLAB) Q2 results: revenue $106.3M beats estimates; non-GAAP loss widens to $0.46/ADS on higher licensing fees.
Array reaffirms $1.4B-$1.5B 2026 revenue while raising adjusted EPS to $0.68-$0.75 (NASDAQ:ARRY)
Array Technologies (ARRY) Q2 2026 earnings call: beat guidance, record $2.5B backlog, raised margin/EPS outlook, and AWM deal.
TaskUs raises 2026 revenue outlook to $1.22B-$1.24B while projecting Q4 AI Services growth above 30% (NASDAQ:TASK)
TaskUs (TASK) Q2 2026 earnings call recap: AI Services and DCX growth, raised revenue/FCF outlook, and largest-client automation headwindsâread key...